Heart failure Pipeline
Heart failure, also known as congestive heart failure refers to the condition when heart is not able to pump adequate blood to the body. In the absence of sufficient blood flow, all the major body functions are disrupted. Certain conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump efficiently. Heart failure can be diagnosed based on the medical and family history, a physical exam, and test results. Treating heart failure depends on the severity of the condition. Diagnostic tests include: electrocardiogram, chest X-Ray, echocardiography etc. Treatments usually include heart-healthy lifestyle changes, medicines, and ongoing care.
DelveInsight’s, “Heart failure Pipeline Insight, 2022” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Heart failure pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight
- Bayer HealthCare Pharmaceuticals
- Ionis Pharmaceuticals
- Heartseed Inc.
- AstraZeneca
- Amgen
- Sardocor Corp.
- Intra-Cellular Therapies
- Bristol Myers Squibb
- Eli Lilly and Company
- Palatin Technologies
- Cardiora
- Zensun Sci. & Tech. Co., Ltd.
- Biopeutics Co., Ltd
- Innolife Co., Ltd.
- SQ Innovation
- scPharmaceuticals
- Mesoblast, Inc
- PhaseBio Pharmaceuticals
- Salubris Biotherapeutics Inc
- Actelion Pharmaceuticals
- Torrent Pharmaceuticals Limited
- Novo Nordisk A/S
- Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
- Merck Sharp & Dohme Corp.
- Cardior Pharmaceuticals GmbH
- Pfizer
- MyoKardia, Inc.
- TransThera Biosciences Co., Ltd
- Acceleron Pharma Inc.
- Asklepios Biopharmaceutical, Inc.
- And Many Others
DelveInsight’s Heart failure report covers around 10+ products under different phases of clinical development like:
- Late-stage products (Phase III)
- Mid-stage products (Phase II and Phase I/II)
- Early-stage products (Phase I/II and Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight
Some of Heart failure Therapies:
- BAY-1753011
- Omecamtiv Mecarbil
- ACRX-100
- GSK2798745
- LMI 1195-101
- And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight
Current Heart failure Treatment Scenario and Heart failure Emerging Therapies:
- How many companies are developing Heart failure drugs?
- How many Heart failure drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Heart failure?
- What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Heart failure therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Heart failure and their status?
- What are the key designations that have been granted to the emerging drugs?
Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight
Table of Contents:
Introduction
Executive Summary
Heart failure: Overview
Pipeline Therapeutics
- Comparative Analysis
Therapeutic Assessment
Heart failure – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Heart failure Collaboration Deals
Late Stage Products (Phase III)
- Comparative Analysis
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
- Comparative Analysis
Drug profiles in the detailed report…..
Pre-clinical and Discovery Stage Products
Drug profiles in the detailed report…..
Inactive Products
- Comparative Analysis
Heart failure Key Companies
Heart failure Key Products
Heart failure- Unmet Needs
Heart failure- Market Drivers and Barriers
Heart failure- Future Perspectives and Conclusion
Heart failure Analyst Views
Heart failure Key Companies
Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight
Get in touch with our Business executive for Rich and Deep Healthcare Consulting Solutions
DelveInsight’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.
Some of Newly Launched Report:
- Acute Lung Injury Market
- Adamantinoma Market
- Defibrillators Market
- Urolithiasis Market
- Cardiac Resynchronization Therapy Device Market
- Aesthetic Implants Market
- Alzheimer Disease Market
- Central Venous Catheters Market
- Biochips Market
- Alopecia Market
- Cardiac Monitoring Devices Market
- Biliary Tumor Market
- Foot And Ankle Devices Market
- Hyperuricemia Market
- Invasive Candidiasis Market
- Global Electrophysiology Devices Market
- Neurovascular Devices Market
- Blood Glucose Monitoring Systems Market
- Neurostimulation Devices Market
- Human Papilomavirus Market
- Capnography Device Market
- Ventilator Market
- Breast Pumps Market
- Metastatic Bone Pain Market
- Brain Aneurysm Stents Market
- Atypical Hemolytic Uremic Syndrome Ahus Market
- 2 Deletion Syndrome Market
- X Linked Hypophosphatemia Market
- Parkinsons Disease Related Dementia Market
- Ocular Motility Disturbance Market
- Palmar Hyperhidrosis Market Size
- Pulse Oximeters Market
- Diagnostic Imaging Equipment Market
- Continuous Renal Replacement Therapy Machines Market
- Pain Management Devices Market
- Glycogen Storage Disease Market
- Rituximab Biosimilars Insight
- Epithelial Ovarian Cancer Market
- Cardiac Biomarkers Testing Devices Market
- Chronic Myelogenous Leukemia Market
- Bone Grafts And Substitutes Market
- Idiopathic Membranous Nephropathy Market
- Advanced Renal Cell Carcinoma Market
- Sialidosis Market
- Prosthetic Joint Infection Market
- Microsatellite Stable Colorectal Cancer Market
- Higher-Risk Chronic Myelomonocytic Leukemia Market
- Chondrosarcoma Market
- Car T Therapy For Acute Lymphoblastic Leukemia All Market
Related Blogs:
- Most Promising Applications of Artificial Intelligence (AI) in Healthcare Segment
- Mapping the Biggest Pharmaceutical Companies by Continents
- Widespread Usage of HPV Vaccine Reduces Cervical Cancers and Precancers
- Major Drugs Decisions for Cardiovascular Diseases to Watch Through 2022
- Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021
- Evaluation of Rapidly Evolving Parkinson’s Disease Therapeutic Market
- Cybersecurity in Healthcare: Major Threats and Challenges
- Top Drugs To Watch in HIV (2025)
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: [email protected]
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
Connect With Us at:
Request for Free Sample Report: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight